316 related articles for article (PubMed ID: 15788203)
21. Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient.
Aksoy S; Abali H; Kilickap S; Erman M; Kars A
Clin Lab Haematol; 2006 Jun; 28(3):211-4. PubMed ID: 16706940
[TBL] [Abstract][Full Text] [Related]
22. [B-cell lymphoma in a woman with chronic hepatitis C and mixed cryoglobulinemia of type 2].
Ignatova TM; Milovanova SIu; Chernova OA; Baĭzhanova ZhZh
Ter Arkh; 2011; 83(4):69-71. PubMed ID: 21675279
[TBL] [Abstract][Full Text] [Related]
23. The relationship between splenic marginal zone B-cell lymphoma and chronic liver disease associated with hepatitis C virus infection.
Moccia F; Tognoni E; Boccaccio P
Ann Ital Med Int; 1999; 14(4):288-93. PubMed ID: 10638021
[TBL] [Abstract][Full Text] [Related]
24. Primary splenic lymphoma in patient with hepatitis C virus infection: case report and review of the literature.
Matone J; Lopes Filho GD; Scalabrin M; Ricca AB; Sato NY
Int Surg; 2000; 85(3):248-51. PubMed ID: 11325005
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus infection, Sjögren's syndrome, and non-Hodgkin's lymphoma.
Selva-O'Callaghan A; Rodriguez-Pardo D; Sanchez-Sitjes L; Matas-Pericas L; Solans-Laque R; Bosch-Gil JA; Vilardell-Tarrés M
Arthritis Rheum; 1999 Nov; 42(11):2489-90. PubMed ID: 10555045
[No Abstract] [Full Text] [Related]
26. Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage.
Zuckerman E; Zuckerman T
Blood Rev; 2002 Jun; 16(2):119-25. PubMed ID: 12127955
[TBL] [Abstract][Full Text] [Related]
27. Lymphoproliferative diseases and hepatitis C virus infection.
Hausfater P; Rosenthal E; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):53-7. PubMed ID: 10761563
[TBL] [Abstract][Full Text] [Related]
28. The pathophysiology of HCV induced B-cell clonal disorders.
Landau DA; Saadoun D; Calabrese LH; Cacoub P
Autoimmun Rev; 2007 Sep; 6(8):581-7. PubMed ID: 17854753
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiology of non-Hodgkin's lymphoma: recent data].
Chassagne-Clément C; Blay JY; Treilleux I; Sebban C; Bergeron C; Biron P; Philip T
Bull Cancer; 1999 Jun; 86(6):529-36. PubMed ID: 10417426
[TBL] [Abstract][Full Text] [Related]
30. Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population.
Idilman R; Bozkus Y; Seval G; Mizrak D; Cinar K; Ustun Y; Bektas M; Arat M; Akbulut H; Doganay B; Ozden A
J Med Virol; 2011 Jun; 83(6):974-80. PubMed ID: 21503909
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus infection and mixed cryoglobulinemia in patients with lymphoproliferative diseases.
Domingo JM; Romero S; Moreno JA; Domingo JA; Callén L; Gutiérrez M
Haematologica; 1999 Jan; 84(1):94-6. PubMed ID: 10091402
[No Abstract] [Full Text] [Related]
32. Hepatitis C virus risk: a hepatitis C virus related syndrome.
Mazzaro C; Panarello G; Tesio F; Santini G; Crovatto M; Mazzi G; Zorat F; Tulissi P; Pussini E; Baracetti S; Campanacci L; Pozzato G
J Intern Med; 2000 May; 247(5):535-45. PubMed ID: 10809992
[TBL] [Abstract][Full Text] [Related]
33. Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection.
Libra M; De Re V; Gloghini A; Callari D; Malaponte G; Travali S; Mazzarino MC; Stivala F; Boiocchi M; Carbone A
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):165-70. PubMed ID: 15990705
[TBL] [Abstract][Full Text] [Related]
34. [Hematologic syndromes in hepatitis C virus infection].
Kryczka W; Kisiel E
Przegl Lek; 2000; 57(11):672-5. PubMed ID: 11293218
[TBL] [Abstract][Full Text] [Related]
35. B-cells and mixed cryoglobulinemia.
Ferri C; Antonelli A; Mascia MT; Sebastiani M; Fallahi P; Ferrari D; Giunti M; Pileri SA; Zignego AL
Autoimmun Rev; 2007 Dec; 7(2):114-20. PubMed ID: 18035320
[TBL] [Abstract][Full Text] [Related]
36. [Hepatitis-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment].
Staak JO; Glossmann JP; Diehl V; Josting A
Med Klin (Munich); 2002 Oct; 97(10):601-8. PubMed ID: 12386793
[TBL] [Abstract][Full Text] [Related]
37. B-lymphoproliferative disorders in patients with hepatitis C virus infection.
Pérez Sánchez I; Rivera Redondo J; García Monforte A; Mayoayo Crespo M; Escudero Soto A; Pintado Cros T
Haematologica; 1998 Oct; 83(10):946-8. PubMed ID: 9830804
[TBL] [Abstract][Full Text] [Related]
38. Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinaemia vasculitis.
Geri G; Terrier B; Semoun O; Saadoun D; Sène D; Charlotte F; Merle-Béral H; Musset L; Resche-Rigon M; Cacoub P
Ann Rheum Dis; 2010 Dec; 69(12):2177-80. PubMed ID: 20876592
[TBL] [Abstract][Full Text] [Related]
39. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
40. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
